Differential expression of caveolin-3 in mouse smooth muscle cells in vivo

Cell and Tissue Research

Volumn 324, Issue 2, 2006, Pages 291-300

  Kogo, Hiroshi ^a,b   Ito, Shin Ya ^a   Moritoki, Yoshinobu ^a   Kurahashi, Hiroki ^b   Fujimoto, Toyoshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Caveolin isoforms; Gastrointestinal muscle; Immunohistochemistry; Mouse (BALB c); Pupillary muscle; Vascular muscle

Indexed keywords

CAVEOLIN 1; CAVEOLIN 3;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; BLADDER; CILIARY MUSCLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; EXTRAOCULAR MUSCLE; FEMALE; GASTROINTESTINAL TRACT; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEMINAL VESICLE; SMOOTH MUSCLE FIBER; URETER; UTERUS; VAS DEFERENS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAVEOLIN 1; CAVEOLIN 3; CELL LINE; DIGESTIVE SYSTEM; EYE; FEMALE; GENITALIA; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TISSUE DISTRIBUTION; URINARY TRACT;

ANIMALIA;

EID: 33645837061     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-005-0130-z     Document Type: Article

References (38)

1. Anderson RGW (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225
2. Bozler E (1948) Conduction, automaticity, and tonus of visceral muscle. Experientia 4:213-218
3. Burnstock G (1970) Structure of smooth muscle and its innervation. In: Tomita T (ed) Smooth muscle. Arnold, London, pp 1-69
4. Capozza F, Cohen AW, Cheung MW, Sotgia F, Schubert W, Battista M, Lee H, Frank PG, Lisanti MP (2005) Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells. Am J Physiol Cell Physiol 288:C677-C691
5. Couet J, Sargiacomo M, Lisanti MP (1997) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272:30429-30438
6. Das K, Lewis RY, Scherer PE, Lisanti MP (1999) The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J Biol Chem 274:18721-18728
7. Deurs B van, Roepstorff K, Hommelgaard AM, Sandvig K (2003) Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 13:92-100
8. Doyle DD, Upshaw-Earley J, Bell E, Palfrey HC (2003) Expression of caveolin-3 in rat aortic vascular smooth muscle cells is determined by developmental state. Biochem Biophys Res Commun 304:22-25
9. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452
10. Fra AM, Williamson E, Simons K, Parton RG (1995) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92:8655-8659
11. Fujimoto T, Hagiwara H, Aoki T, Kogo H, Nomura R (1998) Caveolae: from a morphological point of view. J Electron Microsc Tokyo 47:451-460
12. Fujimoto T, Kogo H, Nomura R, Une T (2000) Isoforms of caveolin-1 and caveolar structure. J Cell Sci 113:3509-3517
13. Galbiati F, Volont D, Minetti C, Chu JB, Lisanti MP (1999) Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of lgmd-1c caveolin-3 mutants within the Golgi complex. J Biol Chem 274:25632-25641
14. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272:25437-25440
15. Hagiwara Y, Nishina Y, Yorifuji H, Kikuchi T (2002) Immunolocalization of caveolin-1 and caveolin-3 in monkey skeletal, cardiac and uterine smooth muscles. Cell Struct Funct 27:375-382
16. Hasegawa K, Arakawa E, Oda S, Yanai N, Obinata M, Matsuda Y (1997) Novel smooth muscle cell lines from transgenic mice harboring temperature-sensitive SV40 large T-antigen gene. Temperature-dependent expression of smooth muscle myosin heavy chain-1 and calponin genes. J Mol Cell Cardiol 29:2177-2186
17. Knight D, D'Arbe M, Liang S, Phillips WD, Lavidis NA (2003) Regional differences in sympathetic purinergic transmission along the length of the mouse vas deferens. Synapse 47:225-235
18. Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, Lisanti MP (1998) Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett 434:127-134
19. Li WP, Liu P, Pilcher BK, Anderson RGW (2001) Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 114:1397-1408
20. van Meer G (2001) Caveolin, cholesterol, and lipid droplets? J Cell Biol 152:F29-34
21. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP (2002) Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160:2207-2217
22. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Knietz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP (2001) Caveolin-1 null mice are viable, but show evidence of hyper-proliferative and vascular abnormalities. J Biol Chem 276:38121-38138
23. Razani B, Lisanti MP (2001a) Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest 108:1553-1561
24. Razani B, Lisanti MP (2001b) Caveolins and caveolae: molecular and functional relationships. Exp Cell Res 271:36-44
25. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RGW (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682
26. Rybin VO, Grabham PW, Elouardighi H, Steinberg SF (2003) Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. Am J Physiol Heart Circ Physiol 285:H325-H332
27. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP (1996) Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93:131-135
28. Segal SS, Brett SE, Sessa WC (1999) Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol 277:H1167-H1177
29. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271:15160-15165
30. Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP (2003) Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. Am J Pathol 163:2619-2634
31. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Minetti C, Sudol M, Lisanti MP (2000) Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan: identification of a central WW-like domain within caveolin family members. J Biol Chem 275:38048-38058
32. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261
33. Toya Y, Schwencke C, Couet J, Lisanti MP, Ishikawa Y (1998) Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 139:2025-2031
34. Venema VJ, Ju H, Zou R, Venema RC (1997) Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272:28187-28190
35. Way M, Parton RG (1996) M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 378:108-112
36. Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, Christ GJ, Lisanti MP (2004a) Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 171:950-957
37. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP (2004b) Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 62:538-543
38. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG Jr, Ishikawa Y (1998) Caveolin is an activator of insulin receptor signaling. J Biol Chem 273:26962-26968